The aim of this study was to assess the pattern of failure and the outcome of endometrial cancer patients and to analyze the variables predictive of the risk of local, distant and retroperitoneal lymph node disease recurrence. PATIENTS AND METHODS: The authors assessed 511 patients who underwent primary surgery. The median follow-up of survivors was 74 months. Peritoneal, hematogenous and lymph node recurrences outside retroperitoneal area were considered as distant failures. RESULTS: Tumor relapsed in 83 (16.2%) patients. Median time to recurrence was 18.5 months (range, 3-129 months). The relapse was local in 13 cases, distant in 37, retroperitoneal in 22, and involved both distant and other sites in 11. Logistic regression sh...
OBJECTIVE: The aim of this study was to evaluate the outcome benefit of follow-up protocols for pati...
Objective: To identify predictors of extensive lymphatic dissemination and distant recurrences in no...
OBJECTIVE: Factors predictive of survival after recurrent early-stage endometrial carcinoma have not...
The aim of this study was to assess the pattern of failure and the outcome of endometrial cancer pat...
Objective: The purpose of this study was to determine the patterns of failure and prognostic factors...
The aim of this retrospective study was to assess the predictive value of different clinicopathologi...
BACKGROUND: The aim of this study was to determine predictors for loco-regional or distant recurrenc...
Purpose: To investigate oncological outcomes and patterns of recurrence of patients undergoing adjuv...
BACKGROUND: Adjuvant therapy increases disease-free survival in endometrial cancer (EC), but has no ...
Background: Byclarifying thesignificance of clinicopathological factors for retroperitoneal lymph no...
Background: The primary objective of this study was to elucidate the predictors for cancer recurrenc...
Objective To determine factors influencing overall survival following recurrence (OSFR) in women wit...
OBJECTIVE: The purpose of this study was to evaluate the patterns of failure, overall survival (OS),...
Objective: To determine factors influencing overall survival following recurrence (OSFR) in women wi...
WOS: 000452166200022Aim: The aim is to identify the risk factors for recurrence and lymphatic metast...
OBJECTIVE: The aim of this study was to evaluate the outcome benefit of follow-up protocols for pati...
Objective: To identify predictors of extensive lymphatic dissemination and distant recurrences in no...
OBJECTIVE: Factors predictive of survival after recurrent early-stage endometrial carcinoma have not...
The aim of this study was to assess the pattern of failure and the outcome of endometrial cancer pat...
Objective: The purpose of this study was to determine the patterns of failure and prognostic factors...
The aim of this retrospective study was to assess the predictive value of different clinicopathologi...
BACKGROUND: The aim of this study was to determine predictors for loco-regional or distant recurrenc...
Purpose: To investigate oncological outcomes and patterns of recurrence of patients undergoing adjuv...
BACKGROUND: Adjuvant therapy increases disease-free survival in endometrial cancer (EC), but has no ...
Background: Byclarifying thesignificance of clinicopathological factors for retroperitoneal lymph no...
Background: The primary objective of this study was to elucidate the predictors for cancer recurrenc...
Objective To determine factors influencing overall survival following recurrence (OSFR) in women wit...
OBJECTIVE: The purpose of this study was to evaluate the patterns of failure, overall survival (OS),...
Objective: To determine factors influencing overall survival following recurrence (OSFR) in women wi...
WOS: 000452166200022Aim: The aim is to identify the risk factors for recurrence and lymphatic metast...
OBJECTIVE: The aim of this study was to evaluate the outcome benefit of follow-up protocols for pati...
Objective: To identify predictors of extensive lymphatic dissemination and distant recurrences in no...
OBJECTIVE: Factors predictive of survival after recurrent early-stage endometrial carcinoma have not...